Prospective study of the relevance of circulating tumor cell status and neoadjuvant chemotherapy effectiveness in early breast cancer

Abstract Although unequivocal evidence has shown the prognostic relevance of circulating tumor cells (CTCs) in patients with metastatic breast cancer (MBC), less evidence is available for its significance in neoadjuvant chemotherapy (NCT) in early breast cancer (BC). Here we conducted an analysis of...

Full description

Bibliographic Details
Main Authors: Chao Ni, Yimin Shen, Qingqing Fang, Min Zhang, Hongjun Yuan, Jingxia Zhang, Miaochun Zhong, Yajuan Zheng
Format: Article
Language:English
Published: Wiley 2020-04-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.2876
id doaj-d0be2544a72f455abac3a060ccbca3ea
record_format Article
spelling doaj-d0be2544a72f455abac3a060ccbca3ea2020-11-25T02:39:04ZengWileyCancer Medicine2045-76342020-04-01972290229810.1002/cam4.2876Prospective study of the relevance of circulating tumor cell status and neoadjuvant chemotherapy effectiveness in early breast cancerChao Ni0Yimin Shen1Qingqing Fang2Min Zhang3Hongjun Yuan4Jingxia Zhang5Miaochun Zhong6Yajuan Zheng7Department of Breast Surgery (Surgical Oncology) The Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou Zhejiang ChinaDepartment of Endocrinology The Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou Zhejiang ChinaDepartment of Breast Surgery Zhejiang Provincial People's Hospital People's Hospital of Hangzhou Medical College Hangzhou Zhejiang ChinaDepartment of Breast Surgery Huzhou Central Hospital Zhejiang University Huzhou Zhejiang ChinaDepartment of Breast Surgery Zhejiang Provincial People's Hospital People's Hospital of Hangzhou Medical College Hangzhou Zhejiang ChinaDepartment of Breast Surgery Zhejiang Provincial People's Hospital People's Hospital of Hangzhou Medical College Hangzhou Zhejiang ChinaDepartment of Breast Surgery Zhejiang Provincial People's Hospital People's Hospital of Hangzhou Medical College Hangzhou Zhejiang ChinaDepartment of Breast Surgery Zhejiang Provincial People's Hospital People's Hospital of Hangzhou Medical College Hangzhou Zhejiang ChinaAbstract Although unequivocal evidence has shown the prognostic relevance of circulating tumor cells (CTCs) in patients with metastatic breast cancer (MBC), less evidence is available for its significance in neoadjuvant chemotherapy (NCT) in early breast cancer (BC). Here we conducted an analysis of individual data from 86 patients confirmed as invasive BC by core‐needle biopsy in Zhejiang Provincial People's Hospital between June 2013 and January 2017. The CTCs were assessed at the time after diagnosis and before surgery with the CanPatrol technique. The median follow‐up duration was 46.3 months. CTCs were detected in 37.2% of all patients (29/78) at baseline, and the presence of CTCs was associated with tumor size, tumor stage, and molecular classification. After NCT, the CTC‐positive patients were dropped from 29 to 8, and the EC‐T (epirubicin/cyclophosphamide followed by docetaxel) and TEC (docetaxel/epirubicin/cyclophosphamide) strategies reduce CTC‐positive patients from 16 to 3 and 13 to 5, respectively. The CTC‐negative conversion rates were similar in ER/PR+ HER2+ (5/7, 71.4%), ER/PR− HER2+ (8/11, 72.7%), and TNBC (7/10, 70%) during NCT. In addition, we explored the association between CTC‐negative conversion and objective response rate (partial response and complete response, ORR) and pathological complete response rate (pCR), and our results indicate that ORR was higher in patients with positive CTCs and converted to negative after NCT (ORR, P = .013; pCR, P = .0608). Our study preliminarily highlights the relevance of CTC status and NCT effectiveness in early BC using the CanPatrol system.https://doi.org/10.1002/cam4.2876CanPatrol systemCTCsearly breast cancerneoadjuvant chemotherapy
collection DOAJ
language English
format Article
sources DOAJ
author Chao Ni
Yimin Shen
Qingqing Fang
Min Zhang
Hongjun Yuan
Jingxia Zhang
Miaochun Zhong
Yajuan Zheng
spellingShingle Chao Ni
Yimin Shen
Qingqing Fang
Min Zhang
Hongjun Yuan
Jingxia Zhang
Miaochun Zhong
Yajuan Zheng
Prospective study of the relevance of circulating tumor cell status and neoadjuvant chemotherapy effectiveness in early breast cancer
Cancer Medicine
CanPatrol system
CTCs
early breast cancer
neoadjuvant chemotherapy
author_facet Chao Ni
Yimin Shen
Qingqing Fang
Min Zhang
Hongjun Yuan
Jingxia Zhang
Miaochun Zhong
Yajuan Zheng
author_sort Chao Ni
title Prospective study of the relevance of circulating tumor cell status and neoadjuvant chemotherapy effectiveness in early breast cancer
title_short Prospective study of the relevance of circulating tumor cell status and neoadjuvant chemotherapy effectiveness in early breast cancer
title_full Prospective study of the relevance of circulating tumor cell status and neoadjuvant chemotherapy effectiveness in early breast cancer
title_fullStr Prospective study of the relevance of circulating tumor cell status and neoadjuvant chemotherapy effectiveness in early breast cancer
title_full_unstemmed Prospective study of the relevance of circulating tumor cell status and neoadjuvant chemotherapy effectiveness in early breast cancer
title_sort prospective study of the relevance of circulating tumor cell status and neoadjuvant chemotherapy effectiveness in early breast cancer
publisher Wiley
series Cancer Medicine
issn 2045-7634
publishDate 2020-04-01
description Abstract Although unequivocal evidence has shown the prognostic relevance of circulating tumor cells (CTCs) in patients with metastatic breast cancer (MBC), less evidence is available for its significance in neoadjuvant chemotherapy (NCT) in early breast cancer (BC). Here we conducted an analysis of individual data from 86 patients confirmed as invasive BC by core‐needle biopsy in Zhejiang Provincial People's Hospital between June 2013 and January 2017. The CTCs were assessed at the time after diagnosis and before surgery with the CanPatrol technique. The median follow‐up duration was 46.3 months. CTCs were detected in 37.2% of all patients (29/78) at baseline, and the presence of CTCs was associated with tumor size, tumor stage, and molecular classification. After NCT, the CTC‐positive patients were dropped from 29 to 8, and the EC‐T (epirubicin/cyclophosphamide followed by docetaxel) and TEC (docetaxel/epirubicin/cyclophosphamide) strategies reduce CTC‐positive patients from 16 to 3 and 13 to 5, respectively. The CTC‐negative conversion rates were similar in ER/PR+ HER2+ (5/7, 71.4%), ER/PR− HER2+ (8/11, 72.7%), and TNBC (7/10, 70%) during NCT. In addition, we explored the association between CTC‐negative conversion and objective response rate (partial response and complete response, ORR) and pathological complete response rate (pCR), and our results indicate that ORR was higher in patients with positive CTCs and converted to negative after NCT (ORR, P = .013; pCR, P = .0608). Our study preliminarily highlights the relevance of CTC status and NCT effectiveness in early BC using the CanPatrol system.
topic CanPatrol system
CTCs
early breast cancer
neoadjuvant chemotherapy
url https://doi.org/10.1002/cam4.2876
work_keys_str_mv AT chaoni prospectivestudyoftherelevanceofcirculatingtumorcellstatusandneoadjuvantchemotherapyeffectivenessinearlybreastcancer
AT yiminshen prospectivestudyoftherelevanceofcirculatingtumorcellstatusandneoadjuvantchemotherapyeffectivenessinearlybreastcancer
AT qingqingfang prospectivestudyoftherelevanceofcirculatingtumorcellstatusandneoadjuvantchemotherapyeffectivenessinearlybreastcancer
AT minzhang prospectivestudyoftherelevanceofcirculatingtumorcellstatusandneoadjuvantchemotherapyeffectivenessinearlybreastcancer
AT hongjunyuan prospectivestudyoftherelevanceofcirculatingtumorcellstatusandneoadjuvantchemotherapyeffectivenessinearlybreastcancer
AT jingxiazhang prospectivestudyoftherelevanceofcirculatingtumorcellstatusandneoadjuvantchemotherapyeffectivenessinearlybreastcancer
AT miaochunzhong prospectivestudyoftherelevanceofcirculatingtumorcellstatusandneoadjuvantchemotherapyeffectivenessinearlybreastcancer
AT yajuanzheng prospectivestudyoftherelevanceofcirculatingtumorcellstatusandneoadjuvantchemotherapyeffectivenessinearlybreastcancer
_version_ 1724787812953227264